Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...

The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...

A brain parasite infects the very cells meant to stop it. Scientists now know how the body still manages to fight back.

Scientists have uncovered a hidden battle between a widespread brain parasite and the immune cells tasked with destroying it. A parasite that can quietly persist in the human brain is capable of ...

Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

QUILT-3.055 is a basket trial evaluating nogapendekin alfa inbakicept across multiple solid tumor types. In the NSCLC cohort, patients received the agent via subcutaneous injection every three weeks ...

KYOTO--Researchers at Kyoto University have identified a new approach to a type of colorectal cancer that is resistant to ...

Researchers have identified a new way to reprogram T cells, which are infection and tumor-fighting white blood cells, so that they have a superior memory, thereby making them more effective in killing ...

Approval of ANKTIVA was granted for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ, with ...

Researchers at the University of British Columbia developed a reliable method to produce helper T cells from stem cells by ...

Researchers have developed a new class of antibodies that amplify the immune system’s ability to fight cancer. By clustering ...